Copper therapy was applied to brindled mouse mutants, which suffer from lethal hypocupraemia, by using cuprous and cupric solutions. The method of treatment was a single subcutaneous injection of 50g of copper at 7 days of age. Early effects of the dose were: prevention of the tremors and spasms seen in untreated mutants, raising to normal and near-normal of caeruloplasmin oxidase and lysyl oxidase activities and pigmentation of skin and fur. Growth of mutants was retarded up to 23 days of age, but thereafter they rapidly gained weight to be nearly normal by 60 days of age. At 3 days after injection, copper concentrations in previously deficient mutant organs apart from liver were at least as much as those of treated normals, which had remained unchanged. Copper in mutant livers had increased only slightly in comparison with the normal control. A state of copper deficiency recurred in mutant tissues by 25 days after injection. A solution of Cu+, retained as such by an alkyl polyether, and sebacic acid resulted in greater growth rates after 23 days than did three other copper treatments. Cu+ may have resulted in an improved growth response owing to it being more readily metabolized than Cu2+. Delayed release of copper from the site of injection may have played an important role.
Mottled mice provide an animal model of the congenital copper-deficiency disease, Menkes' syndrome, and are excellent for studies of copper metabolism (Hunt, 1974 (Hunt, , 1976 Camakaris et al., 1979) .
Previous reports of copper therapy in brindled males (Mobr/Y) have demonstrated increased survival up to 28 days of age, but only moderate improvement in weight gain (Hunt, 1976) . Up to now, copper therapy of infants with Menkes' syndrome has proved of little benefit, if Cu-histidine, Cu-EDTA or Cu-albumin complexes were used. However, treatment in these cases was not usually commenced until at least 2 months after birth, and some irrepairable damage may have occurred (Danks, 1977) . Henkin (1978) has reported patients treated from the first days or weeks of life with oral Cu-nitriloacetate with very variable clinical results; none of the patients were normal; penetration of copper to the brain was particularly poor.
The present paper describes results of various forms of copper therapy of brindled (Mobr/Y) mice and reports survival to 10 months with normal growth and fertility in treated males. Vol. 180
Experimental
The mouse strain used possessed the lethal mutant gene brindled (br), an allele at the mottled locus (Fraser & Sobey, 1953) . The affected male mice (MobrIY) die at around 14 days post partum. Adult mice were fed on Mecon rat and mouse cubes ad libitum containing 16.7,g of copper/g dry wt., and acidified water containing 2.5 pg of copper/ml and were housed in plastic boxes with steel tops.
Mice were treated with one of eight copper solutions (Table 1) . Alkyl polyether is a compound capable of retaining copper in its reduced state (Cu+), and was kindly supplied by I.C.I. (Australia) Ltd. Research Department, Newson Street, Ascot Vale, Vic., Australia. This substance is toxic in large doses, so was diluted to 10 % (v/v) , at which it is still capable of retaining Cu+. The Cu+ in this solution precipitates if exposed to water, so the diluent chosen was propane-1,2-diol, which is non-toxic and sufficiently non-viscous for injection. Alkyl polyether was shown to retain at least 99 % Cu+ by polarographic, n.m.r. and iodometric techniques (E. G. Walliczek, unpublished work). Sebacic acid was added to some of Mice were killed at the ages indicated and copper concentrations of various organs were measured by the method of Stevens (1972) . Copper was assayed by using the Varian-Techtron CRA-90 atomic absorption spectrophotometer, containing the BC-6 background-subtract module. Caeruloplasmin was assayed by the method described in the preceding paper ).
Results
Influence ofdifferent copper solutions used These are listed in Table 1 . Administration of 50,ug of copper as Cu-EDTA or Cu-histidine proved very toxic to the young mice, resulting in death of both normals and mutants in less than 24h after injection. In the form of CuS04 (aq.), 50,ug of copper was also toxic to mutants, resulting in nervous-system damage evident by gross ataxia, whereas an equivalent dose of CuC12 (aq.) or of the other four remaining copper solutions caused no such symptoms. Subsequent therapy was therefore restricted to Cu+Seb(p), Cu2+Seb(p), Cu+(p) and Cu2+(p) solutions (Table 1) .
Choice ofdose and age ofadministration Table 2 shows that a 50,ug injection of copper was more effective than the smaller doses, resulting in the most frequent survival of mutants up to 60 days of age. With doses of 200,ug and 100,ug, growth stunting and nervous-system damage were frequent in mutants. Administration of 50ug of copper at 9 days or later resulted in a decreased survival of mutants; the later the injection, the less successful the treat-1979 (Table 3) and Iysyl oxidase activity in urea extracts of skin (Rowe et al., 1977) was near normal (Royce et al., 1978) , these enzymes being severely deficient in untreated mutants. However, caeruloplasmin oxidase activity had fallen by 11 days after injection and was very low by 32 days (Table 4) . Urinary excretion of copper was high in mutants 3 days after injection (Table 3) . Vol. 180
Effect on growth and survival Fig. 1 shows that the weight gain in mutants was very slow for as long as 23 days after treatment with any of the four solutions, but then mutants put on weight at a faster rate than normals (Fig. 2 ). Mutants treated with Cu+Seb(p) showed significantly better catch-up growth than those in the other three treatment groups, reaching near-normal weight by 60 days (Fig. 1) . Their rapid growth phase began earlier than that of the other treatment groups, except those with Cu+(p), and there was an extra growth spurt at 34-47 days (Fig. 2) . Growth of normal mice was unaffected by treatment, and these have been grouped together in the graphs.
This weight gain was a true catch-up growth phenomenon involving all parts of the body (Table  5 ). The mutant adult males are healthy and vigorous (more so than viable blotchy mutants), and the first mice treated in our laboratory have now survived to 10 months of age. Apart from having pale-grey fur and kinky whiskers, they appear and behave normally, and are also fertile. Mutant females (Mobr/br) .
Discussion
These experiments show that it is possible to achieve long-term survival, near-normal growth and fertility in both affected males and homozygous affected females for the brindled mutation with a single dose of subcutaneous copper administered at day 7. This will allow considerably more investigations of the effects of this mutation to be carried out. It is indeed surprising that a single dose has produced such a long-term benefit. Clearly, more experiments will be required to understand this process fully, but certain features are already apparent.
The changes in coat colour that occurred in the first 24h after treatment, and the fact that lysyl oxidase activity of skin and caeruloplasmin oxidase activity returned to nearly normal values in samples obtained 3 days after injection, indicate that the copper was able to restore the function of at least three of the copper enzymes (tyrosinase, lysyl oxidase and caeruloplasmin) quite promptly. Presumably the copper is also effective in the crosslinking process in keratin, as evidenced by the change in the shape of the vibrissae. Further study of these processes at different times after treatment and study of other copper enzymes in treated animals will be of great interest.
Interpretation of the effects of copper therapy on growth is more difficult. Clearly the copper therapy has a beneficial effect in the long term, but the very slow growth observed in the first 16 days after treatment is a puzzle. One might attribute this to toxicity of the copper during this phase, especially since higher doses did cause frank neurological toxicity. Treated normal mice showed slower growth rates than untreated controls during the first 3 days after treatment, suggesting transient toxicity; however, growth rates of treated and untreated normal mice were identical after this time.
On examining the longer-term growth it is apparent that Cu+Seb(p) caused a significantly better outcome than any of the other forms of copper used. This finding suggests a synergistic effect between Cu+ and sebacate. It is known that copper has to be in the Cu+ form for incorporation into a number of copper enzymes (Osterberg, 1974; Frieden & Hsieh, 1976) . Copper may also penetrate membranes as Cu+ (Osterberg, 1974 The severe toxicity of Cu-EDTA, Cu-histidine and CuS04 was surprising, since these have been the forms ofcopper that have generally been administered to human patients with Menkes' syndrome, and toxic effects have been described only rarely (Danks et al., 1972; Wehinger et al., 1975) ; however, these mice were given far more copper than any human patient has ever been given in a single day. The single subcutaneous dose was 11 000ug of copper/kg body wt., whereas human dosage has generally been 200-500g/kg in a single day. This subcutaneous injection causes a significant portion of the dose to build up in the skin (Table 3) , thereby acting as a depot dose which probably allows a slow release of copper to tissues. Retention of "4Cu at the site of injection was demonstrated in an experiment where "4Cu was injected into the right thigh muscle of normal and mutant mice. After 24h, 25% of the administered dose was recovered at the injection site in the mutants compared with 15% at this site in normals. The values for left thigh muscle were 1 % in mutants and 0.3 % in normals. These data also provide evidence for greater retention in the mutants.
The studies of the distribution of copper in various tissues after treatment are of considerable interest, although not all the observations are immediately interpretable. They need to be considered in the light of the copper accumulation found in cells cultured from mice (Danks, 1977; Danks et al., 1978) and from humans (Goka et al., 1976; Horn, 1976; Beratis et al., 1978; Danks et al., 1978) and of kinetic studies performed with 64Cu .
The increase in the kidney concentration of copper in mutant mice 3 days after injection is very striking. This finding is in accord with those observations in tissue culture just mentioned. Muscle and skin appear to show the same phenomenon of excessive copper content after therapy. The findings in brain, spleen and lung are less interpretable.
The findings in the liver were in striking contrast. Normal mice showed massive accumulation of copper, whereas mutants showed only a small increase from the very low concentration present in the liver before treatment. However, the fact that caeruloplasmin oxidase activity came back to normal in mutants for a period of time indicates that the copper present in the liver was available for caerulo-plasmin synthesis. By 53 days after treatment, the liver copper concentrations of mutants and normals were similar, yet the caeruloplasmin oxidase activity of mutants was very low.
Others who have observed low liver copper concentrations in mutants after copper administration have described this as 'diminished hepatic uptake' (Hunt, 1976; Van den Hamer & Prins, 1978; Evans & Reis, 1978) . However, kinetic studies with 64Cu showed that the initial uptake of copper in the first 10min was identical in normal and mutant mice and that the problem really is one of diminished hepatic retention . From these observations it may seem that the basic defect decreases the capacity of liver cells to retain copper. This would explain the intermediate concentration ofliver copper in treated heterozygote mice. However, this is the converse of the expression of the basic defect suggested above for fibroblastic cells, renalepithelial cells and intact kidney, which is accumulation of excessive amounts of copper. This contradiction will need to be examined further, but the liver results may possibly be explained by diversion of copper to other tissues with increased ability to accumulate copper, and by excessive renal excretion. Decreased exposure of liver cells to copper in utero may have prevented development of binding sites for long-term retention.
The normal amounts of copper in mutant adult gut cells are consistent with the contention that the high concentration of copper in the lower region of the small intestine of untreated neonatal mutants is the result of pinocytosis , as this process terminates by 18 days of age (Clark, 1959) .
A prolonged beneficial effect is produced by a single dose of copper in these animals despite the return of many abnormalities attributable to the failure of copper enzymes. The skin loses most of its pigmentation and the vibrissae go back to their abnormal shape. Lysyl oxidase activity is undetectable in skin at 60 days (Royce et al., 1978) ; however, the long life ofcollagen and elastin molecules may allow normality of connective tissue for many months. Apparently those components of a disease which usually cause death at 12-16 days do not recur to a serious degree. These vital effects remain to be identified. Presumably, even better results could be obtained by long-term intermittent therapy starting at 7 days or earlier.
